Hereditary Angioedema Market Size And Share

  • Report Code : TIPRE00005410
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Marktgröße für hereditäres Angioödem, Anteilsanalyse bis 2025-2031

Buy Now

Hereditary Angioedema Market Report Hereditary Angioedema Market Scope and Analysis Hereditary Angioedema Market Size and Share

Hereditary Angioedema Market Report Analysis

Hereditary Angioedema Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BIOCRYST PHARMACEUTICALS, INC
  • CSL
  • Ionis Pharmaceuticals, Inc.
  • Merck Sharp & Dohme Corp
  • Pharming Group N. V.
  • Sanofi N. V.
  • Shire plc.
  • Teva Pharmaceutical Industries, Ltd.
  • Attune Pharmaceuticals

Regional Overview

  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika
  • Naher Osten und Afrika

Market Segmentation

By Medikamente
  • C1-Esterase-Inhibitor
  • Kallikrein-Inhibitor
  • Bradykinin-Rezeptor
  • abgeschwächte Androgene
  • andere
By Verabreichungsweg
  • subkutan
  • intravenös
  • oral
By Vertriebskanal
  • Krankenhausapotheken
  • Einzelhandelsapotheken
  • E-Commerce
By Geographie
  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika